| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/29/1995 | CN1100649A Medicine for relieving inflammation and pain |
| 03/29/1995 | CN1100648A Oral liquid for burns |
| 03/29/1995 | CN1100646A Drug-withdrawal tea and method for prepn. |
| 03/29/1995 | CN1100645A Health-care bolus for invigorating kidney and improving sexual function |
| 03/29/1995 | CN1100641A Chinese herbal medicine for curing women disease |
| 03/29/1995 | CN1028024C Method for preparation of tetrazole excitatory amino acid receptor antagonists |
| 03/29/1995 | CA2117394A1 Biodegradable implant precursor |
| 03/28/1995 | US5401741 Cream with ofloxacin for inflammation of ears |
| 03/28/1995 | US5401634 Stable biologically active fluorochemical emulsions |
| 03/28/1995 | US5401516 Encapsulation of biologically active materials, drug delivery, reaction with benzenesulfonyl chloride or benzoyl chloride |
| 03/28/1995 | US5401515 Coated active agent-containing article |
| 03/28/1995 | US5401514 Solid, fast-soluble pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetylcysteine |
| 03/28/1995 | US5401513 Magnesium carbonate and oil tableting aid and flavoring additive |
| 03/28/1995 | US5401512 Antiulcer agents with 5-aminosalicylic acid with topical steroids |
| 03/28/1995 | US5401511 Phosphatidylethanolamine, hyaluronic acid, drug delivery |
| 03/28/1995 | US5401510 Wound healing modulators, non-steroidal antiinflammatory agents |
| 03/28/1995 | US5401509 Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation |
| 03/28/1995 | US5401507 Drug delivery |
| 03/28/1995 | US5401502 Pellets containing plant extracts, process of making same and their pharmaceutical peroral or cosmetic use |
| 03/28/1995 | US5401499 With polymine from an aziridine compound |
| 03/28/1995 | US5401496 Oral anti-halitosis preparations |
| 03/28/1995 | CA2029046C Sustained release compositions for treating periodontal disease |
| 03/28/1995 | CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
| 03/28/1995 | CA1334935C Dithranol compositions |
| 03/28/1995 | CA1334934C Antibacterial composition for oral administration |
| 03/28/1995 | CA1334933C Pharmaceutical composition and process for its preparation |
| 03/28/1995 | CA1334920C Use of parenchymal cell cellulose to improve comestibles |
| 03/23/1995 | WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto |
| 03/23/1995 | WO1995007936A1 Dextrane esters, process for producing them and their use for encasing and encapsulating medicaments |
| 03/23/1995 | WO1995007902A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 03/23/1995 | WO1995007817A1 Multilayer halogen-free barrier film |
| 03/23/1995 | WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 03/23/1995 | WO1995007701A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 03/23/1995 | WO1995007699A1 Novel method of progesterone delivery and affect thereof |
| 03/23/1995 | WO1995007696A1 Pharmaceutical composition of hiv-protease inhibitors |
| 03/23/1995 | WO1995007692A1 Viscous surfactant emulsion compositions |
| 03/23/1995 | WO1995007689A1 Compositions containing swelling pharmaceuticals |
| 03/23/1995 | WO1995007683A1 Composition containing phosphate derivatives |
| 03/23/1995 | WO1995007672A1 Rectally-administered, epileptic-seizure-inhibiting composition |
| 03/23/1995 | WO1995005416A3 Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
| 03/23/1995 | DE4331903A1 Process for producing cocoa butter substitute from tea seed oil by catalytic hydrogenation and transesterification |
| 03/23/1995 | CA2171829A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 03/23/1995 | CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 03/23/1995 | CA2170489A1 Composition containing phosphate derivatives |
| 03/23/1995 | CA2167412A1 Pharmaceutical composition of hiv-protease inhibitors |
| 03/23/1995 | CA2132511A1 Use of partly methylated .beta.-cyclodextrines as absorption promoters for the preparation of pharmaceutical compositions to be used for transcutaneous dispensing of activeingredients |
| 03/22/1995 | EP0643968A1 Molded pharmaceutical form for oral delivery of acetylsalicyclic acid or its salts and method to prepare it |
| 03/22/1995 | EP0643965A1 Nicotinic acid compositions for treating hyperlipidemia |
| 03/22/1995 | EP0643963A2 Bioerodible device for administering active ingredients |
| 03/22/1995 | EP0643962A1 New galenic dosage form for phloroglucinol |
| 03/22/1995 | EP0643737A1 Conversion of powdered polymers |
| 03/22/1995 | EP0643620A1 Particles, method of preparing said particles and uses thereof |
| 03/22/1995 | EP0643578A1 A new composition containing selegiline |
| 03/22/1995 | EP0643575A1 Metering spray designed for pernasal application. |
| 03/22/1995 | EP0585355B1 Multi-layered controlled release formulation |
| 03/22/1995 | EP0527803B1 Composition for macrophage activation |
| 03/22/1995 | EP0502054B1 An aerosol preparation of glutathione and a method for augmenting glutathione level in lungs |
| 03/22/1995 | CN2192331Y Recovered bag with lowering carbohydrate metabolism |
| 03/22/1995 | CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates |
| 03/22/1995 | CN1100416A Derivative of 2-amino-N-ÛÛÛ4-(aminocarbonyl)pyrimidin-2-ylÙamizoÙalkylÙpyrimidiny-4-carboxamide, preparation and pharmaceutical application of same |
| 03/22/1995 | CN1100323A Hyptis suavedens round chewing gum and its preparing technology |
| 03/22/1995 | CN1100314A Chinese herb medicine for treating rhinitis |
| 03/22/1995 | CN1100313A Chinese herb medicine for treating pharyngitis |
| 03/22/1995 | CN1100301A Drug for neuroprotection |
| 03/22/1995 | CA2132368A1 Wound implant materials |
| 03/21/1995 | US5399551 Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin |
| 03/21/1995 | US5399363 IV administration for insoluble medicaments |
| 03/21/1995 | US5399362 Once-a-day metoprolol oral dosage form |
| 03/21/1995 | US5399361 Collagen-containing sponges as drug delivery compositions for proteins |
| 03/21/1995 | US5399360 Pharmaceutical compositions |
| 03/21/1995 | US5399359 Controlled release oxybutynin formulations |
| 03/21/1995 | US5399358 Sustained release formulations for 24 hour release of metroprolol |
| 03/21/1995 | US5399357 Sustained release preparations |
| 03/21/1995 | US5399356 Process for making solid dose forms containing bismuth |
| 03/21/1995 | US5399355 Uniform penetration through skin |
| 03/21/1995 | US5399354 Process for making a hard-candy based oral pharmaceutical lozenge containing an antacid |
| 03/21/1995 | US5399350 Proteinaceous oil spill dispersant |
| 03/21/1995 | US5399341 Use of cytokin-containing aerosols and the cytokin-containing aerosols |
| 03/21/1995 | US5399331 Method for protein-liposome coupling |
| 03/21/1995 | US5398698 Process for preparing an intravaginal application system |
| 03/21/1995 | CA2132396A1 Physiologically active substance-prolonged releasing-type pharmaceuticalpreparation |
| 03/21/1995 | CA2037057C Photostabilizing method for ophthalmic solutions and the resulting opthalmic solutions therefrom |
| 03/21/1995 | CA2006714C Absorbable coating and blend |
| 03/21/1995 | CA2003198C Aqueous ophthalmic solutions and method for preserving same |
| 03/21/1995 | CA1334846C Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use |
| 03/21/1995 | CA1334828C Process for the preparation of a powdered extract of valerian roots |
| 03/16/1995 | WO1995007105A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 03/16/1995 | WO1995007097A1 Inhibition of heparin-binding |
| 03/16/1995 | WO1995007085A1 Surface active viscoelastic solutions for ocular use |
| 03/16/1995 | WO1995007083A1 Ifosfamide lyophilisate composition |
| 03/16/1995 | WO1995007082A1 A combination tablet comprising acetylsalicylic acid and a process for the preparation thereof |
| 03/16/1995 | WO1995007076A1 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, process for the preparation thereof, pharmaceutical preparations containing these inclusion complexes or containing optically active s-(+)-ibuproxam, and use thereof |
| 03/16/1995 | WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/16/1995 | WO1995007072A2 Active principles and gas containing microparticles |
| 03/16/1995 | WO1995007071A1 Multi-phase compositions for an initial and delayed release of a medicament |
| 03/16/1995 | WO1995007070A1 Effervescent granulated material and method for its preparation |
| 03/16/1995 | WO1995007049A1 Diagnostic uses of hydrazinoadenosines |
| 03/16/1995 | WO1995004528A3 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE |
| 03/16/1995 | WO1995003786A3 New pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives |
| 03/16/1995 | WO1995003050A3 Improved nicotine lozenge and therapeutic method for smoking cessation |